Home/Filings/4/0001104659-22-128768
4//SEC Filing

Alkon Daniel L. 4

Accession 0001104659-22-128768

CIK 0001571934other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 8:01 PM ET

Size

5.0 KB

Accession

0001104659-22-128768

Insider Transaction Report

Form 4
Period: 2022-12-16
Alkon Daniel L.
DirectorChief Scientific Officer
Transactions
  • Sale

    Common Stock, par value $0.0001 per share

    2022-12-16$1.17/sh19,688$23,07235,546 total
Footnotes (1)
  • [F1]Shares sold pursuant to a Rule 10b5-1 sales plan, entered into on December 6, 2021 and amended and restated on October 24, 2022, to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Issuer

Synaptogenix, Inc.

CIK 0001571934

Entity typeother

Related Parties

1
  • filerCIK 0001686138

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 8:01 PM ET
Size
5.0 KB